Serum Lipidomics Profiling to Identify Biomarkers for Non-Small Cell Lung Cancer

Table 1

The clinical characteristics of early-stage NSCLC, HC, and LBD enrolled in this study.

Characteristics	Non-targeted lipidomics			Targeted lipidomics
	NSCLC	LBD	HC	NSCLC	LBD	HC
Sample size	66	40	40	30	30	30
Age range (years)	61.5±8.2	59.2±10.0	54.0±7.5	62.1±6.7	53.9±11.2	51.7±7.1
Gender
male	40	21	24	21	18	19
female	26	19	16	9	12	11
Pathological type
ADC	35	- -	- -	15	- -	- -
SqCC	31	- -	- -	15	- -	- -
TNM Stages
Stage I	38	- -	- -	15	- -	- -
Stage II	28	- -	- -	15	- -	- -

Union for International Cancer Control (UICC) TNM Classification of Lung Cancer (8th ed., 2017).
NSCLC, non-small cell lung cancer; LBD, lung benign disease; HC, healthy controls; ADC, lung adenocarcinoma; SqCC, lung squamous cell carcinoma.